Harrison, NY17 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Harrison, NY

Find 17 actively recruiting myalgic encephalomyelitis clinical trials in Harrison, NY. Connect with local research sites and explore new treatment options.

17
Active Trials
1
Sponsors
3,178
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Harrison

About Myalgic Encephalomyelitis Clinical Trials in Harrison

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 17 myalgic encephalomyelitis clinical trials recruiting participants in Harrison, NY. These studies are seeking a combined 3,178 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Harrison — FAQ

Are there myalgic encephalomyelitis clinical trials in Harrison?

Yes, there are 17 myalgic encephalomyelitis clinical trials currently recruiting in Harrison, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Harrison?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Harrison research site will contact you about next steps.

Are clinical trials in Harrison free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Harrison studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 17 active trials in Harrison are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov